SPG20 抗体 (Middle Region)
-
- 抗原 See all SPG20 抗体
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
-
抗原表位
- Middle Region
-
适用
- 人, 小鼠, 大鼠, 马, Cow, 犬, 兔, 豚鼠, 斑马鱼
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This SPG20 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 序列
- ASWVSWGLVK GAEITGKAIQ KGASKLRERI QPEEKPVEVS PAVTKGLYIA
- 预测反应
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 79%
- 产品特性
- This is a rabbit polyclonal antibody against SPG20. It was validated on Western Blot using a cell lysate as a positive control.
- 纯化方法
- Affinity Purified
- 免疫原
- The immunogen is a synthetic peptide directed towards the middle region of human SPG20
- Top Product
- Discover our top product SPG20 Primary Antibody
-
anti-Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (AA 18-45), (N-Term) antibody
SPG20 适用: 人 WB, FACS, IHC (p) 宿主: 兔 Polyclonal RB22531 unconjugated
anti-Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (AA 24-54), (N-Term) antibodySPG20 适用: 人 WB, FACS, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
anti-Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (AA 431-480) antibodySPG20 适用: 人, 小鼠, 大鼠, 马, Cow, 犬, 兔, 豚鼠, 猴, Bat, Pig, Hamster WB 宿主: 兔 Polyclonal unconjugated
anti-Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (AA 1-350) antibodySPG20 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- Optimal working dilutions should be determined experimentally by the investigator.
- 说明
-
Antigen size: 666 AA
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
- 抗原
- SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
- 别名
- SPG20 (SPG20 产品)
- 别名
- SPARTIN antibody, TAHCCP1 antibody, AI840044 antibody, C79168 antibody, mKIAA0610 antibody, spartin antibody, Spg20 antibody, spg20a antibody, zgc:172059 antibody, spg20b antibody, zgc:153766 antibody, spartin antibody, spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) antibody, spartin a antibody, spartin b antibody, SPART antibody, Spg20 antibody, Spart antibody, sparta antibody, spartb antibody
- 背景
-
This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome).
Alias Symbols: KIAA0610, SPARTIN, TAHCCP1
Protein Interaction Partner: UBC, WWOX, ITCH, PLIN3, SMURF2, ZFYVE9, APP, EPS15, SMURF1, WWP2, WWP1, SUMO2, KLC2, AIFM1, VIM, NCL, LMNB1, KPNB1, KIF5B, HSPD1, HSPA9, HSPA5, HADHA, ACSL4, ACSL3, DYNC1H1, COPA, CLTC, TUBA1A,
Protein Size: 666 - 分子量
- 73 kDa
- 基因ID
- 23111
- NCBI登录号
- NM_015087, NP_055902
- UniProt
- Q8N0X7
- 途径
- Regulation of Cell Size, SARS-CoV-2 Protein Interactome
-
